Disclosure of large shareholding
16.10.2020
KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
PRIVATE PLACEMENT SUCCESSFULLY PLACED
CONTEMPLATED PRIVATE PLACEMENT – INTENDED TRANSFER OF LISTING TO OSLO BØRS
15.10.2020
PROGO’s BIOACTIVE PEPTIDES TO SUPPORT HEALTHY IRON LEVELS TO BE LAUNCHED IN THE U.S.
13.10.2020
HBC’S APPLICATION TO HEALTH CANADA FOR UNIQUE QUALIFIED HEALTH CLAIMS IS PROGRESSING VERY WELL AND A POSITIVE CONCLUSION IS EXPECTED DURING OCTOBER 2020
06.10.2020
ANNOUNCES THE USE OF A VIRTUAL PLATFORM TO RECRUIT COVID-19 PATIENTS IN CANADA TO THE PHASE 2 TRIAL. WILL ALSO ASSESS THE IMPACT OF OMEGO ON HOSPITALISED PATIENTS WITH SEVERE FORMS OF COVID-19 IN MEXICO AND BRAZIL
24.09.2020
SHARE CAPITAL INCREASE REGISTERED
18.09.2020
New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD
01.09.2020
ISSUANCE OF NEW SHARES FOLLOWING EXERCISE OF OPTIONS – PRIMARY INSIDER DISCLOSURE
28.08.2020